Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Immunologic determinants of infusion products and the tumor microenvironment govern response to TIL therapy in advanced melanoma.
Journal: Med (New York, N.Y.)
Published: March 17, 2026
Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy.
Journal: Nature cancer
Published: January 09, 2024
Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients.
Journal: Journal for immunotherapy of cancer
Published: September 13, 2023
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.
Journal: Frontiers in immunology
Published: August 09, 2023
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 06, 2022
Assessment of the LOVO device for final harvest of novel cell therapies: a Production Assistance for Cellular Therapies multi-center study.
Journal: Cytotherapy
Published: October 24, 2021
Expansion and Enrichment of Gamma-Delta (γδ) T Cells from Apheresed Human Product.
Journal: Journal of visualized experiments : JoVE
Published: October 11, 2021
Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting Cells.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: August 26, 2021
Manufacturing Dendritic Cells for Immunotherapy: Monocyte Enrichment.
Journal: Molecular therapy. Methods & clinical development
Published: February 15, 2020
Last Updated: 09/26/2026